Dividends CalendarEarnings Calendar

UMRX | Unum Therapeutics Inc.

Unum Therapeutics Inc.
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Massachusetts, United States

Trade prices

  • Volume:
  • Market Cap: 99.38M
  • Prev closed: 2.88
  • Open: 2.81
  • High: 2.9
  • Low: 2.73
  • 52 week low: 0.3
  • 52 week high: 3.72
  • Dividends:No Dividends

Next ER: November 10, 2020 



Top Stories (UMRX)

    Company Profile

    Unum Therapeutics is a biopharmaceutical company focused on developing curative cell therapies to treat patients with advanced cancers. Unum’s novel proprietary technology called Bolt-On Chimeric Receptor (BOXR) is designed to improve the functionality of engineered T cells by discovering and incorporating a “bolt-on” transgene into a patients’ engineered T cells to overcome resistance of the solid tumor microenvironment to T cell attack. Unum’s BOXR1030, the first preclinical product candidate to emerge from the BOXR platform, is composed of a GPC3-targeted CAR T cell and a “bolt-on” enzyme called glutamic-oxaloacetic transaminase 2 (GOT2) that aims to improve T cell function in the solid tumor microenvironment through enhanced metabolism. GOT2 plays a central metabolic role by linking multiple pathways involved in biosynthesis and cellular energy production.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    November 17, 2020- / -0.14- / 1.5M
    August 12, 2020-0.24 / -0.21528K / 1.5MBeat!
    May 11, 2020-0.2 / -0.37.03M / 2MBeat!
    March 26, 20200.07 / -0.2715.29M / 3.74MBeat!
    November 12, 2019-0.39 / -0.311.02M / 3.52M
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Nov 10, 2020 11.0900 10.7800
    11.7800
    9.9700
    274.47K 10.35%
    Nov 9, 2020 10.0500 9.1500
    13.9000
    9.1500
    338.32K 2.55%
    Nov 6, 2020 9.8000 10.0000
    10.2400
    9.4000
    63.21K -1.61%
    Nov 5, 2020 9.9600 10.8400
    10.8400
    9.8000
    93.68K -5.32%
    Nov 4, 2020 10.5200 10.8800
    11.4000
    10.0000
    223.17K -2.59%
    Nov 3, 2020 10.8000 11.1200
    11.9200
    10.6000
    191.96K -9.4%
    Nov 2, 2020 11.9200 11.5600
    12.0800
    10.5200
    730.74K -3.25%
    Oct 30, 2020 12.3200 10.9600
    12.4400
    10.2400
    372.61K 8.07%
    Oct 29, 2020 11.4000 11.6000
    11.9600
    11.0400
    114.83K -3.39%
    Oct 28, 2020 11.8000 12.4400
    12.8000
    10.7200
    384.69K -8.1%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2014
    • Employees:29

    News

    News for (UMRX)

    This company doesn't provide a dividend.

    Key Persons

    • CFO :  John Green

    Talk about Unum Therapeutics Inc. below in comments section below.

    Do you think you'll buy? Do you already have active trades now?




    Other ER on Nov 10, 2020 (Same day)

    aap ash rok cybr athm.ch dhi sanm crbp lyft jmia vslr goss 


    Jump to (Finance sites)

    Their Official Profiles 

    TwitterLinkedIn

    Other stocks 

    snap jnj t s orcl hd dri kmx ctas kr agro keys 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Currency Trading For Dummies
    Buy on Amazon

    Currency Trading For Dummies is a hands-on, user-friendly guide that explains how the foreign exchange (ForEx) market works and how you can become a part of it. Currency trading has many benefits, but it also has fast-changing financial-trading avenues. ForEx markets are always moving. So how do you keep up?